JP7657727B2 - 抗原性多量体呼吸器合胞体ウイルスポリペプチド - Google Patents
抗原性多量体呼吸器合胞体ウイルスポリペプチド Download PDFInfo
- Publication number
- JP7657727B2 JP7657727B2 JP2021558831A JP2021558831A JP7657727B2 JP 7657727 B2 JP7657727 B2 JP 7657727B2 JP 2021558831 A JP2021558831 A JP 2021558831A JP 2021558831 A JP2021558831 A JP 2021558831A JP 7657727 B2 JP7657727 B2 JP 7657727B2
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- polypeptide
- gcc
- antigenic
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18571—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025003856A JP2025063151A (ja) | 2019-04-02 | 2025-01-10 | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962828302P | 2019-04-02 | 2019-04-02 | |
| US62/828,302 | 2019-04-02 | ||
| PCT/US2020/026198 WO2020205986A1 (en) | 2019-04-02 | 2020-04-01 | Antigenic multimeric respiratory syncytial virus polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003856A Division JP2025063151A (ja) | 2019-04-02 | 2025-01-10 | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525431A JP2022525431A (ja) | 2022-05-13 |
| JP2022525431A5 JP2022525431A5 (cg-RX-API-DMAC10.html) | 2024-07-12 |
| JP7657727B2 true JP7657727B2 (ja) | 2025-04-07 |
Family
ID=70465435
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558831A Active JP7657727B2 (ja) | 2019-04-02 | 2020-04-01 | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
| JP2025003856A Pending JP2025063151A (ja) | 2019-04-02 | 2025-01-10 | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003856A Pending JP2025063151A (ja) | 2019-04-02 | 2025-01-10 | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12454553B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3946446A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7657727B2 (cg-RX-API-DMAC10.html) |
| CN (2) | CN114269373A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020205986A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7657727B2 (ja) | 2019-04-02 | 2025-04-07 | サノフイ | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
| US11608458B2 (en) | 2019-12-19 | 2023-03-21 | Prc-Desoto International, Inc. | Adhesion-promoting interlayer compositions containing organic titanates/zirconates and methods of use |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000512136A (ja) | 1996-06-05 | 2000-09-19 | バイオモレキュラー・リサーチ・インスティテュート・リミテッド | 呼吸器合胞体ウイルスのgタンパク質と構造的ホモロジーを有するウイルス性ペプチド |
| WO2019032480A1 (en) | 2017-08-07 | 2019-02-14 | Avatar Medical, Llc | PROTEINS F PRE-FUSION OF RSV STABILIZED IN TERMS OF CONFORMATION |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| ATE178906T1 (de) * | 1994-08-25 | 1999-04-15 | Stichting Inst Dierhouderij | Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen |
| CA2281838A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| US6218371B1 (en) | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| KR100938105B1 (ko) * | 2007-09-21 | 2010-01-21 | 이화여자대학교 산학협력단 | 호흡기 신시치아 바이러스 백신 |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| US9060975B2 (en) | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
| US9703095B2 (en) | 2015-01-05 | 2017-07-11 | Edward Pakhchyan | Light modulator for MEMS display |
| WO2016160166A1 (en) * | 2015-03-30 | 2016-10-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic rsv polypeptides |
| US20180271970A1 (en) * | 2015-10-22 | 2018-09-27 | Modernatx, Inc. | Respiratory syncytial virus vaccine |
| KR102724939B1 (ko) | 2016-06-17 | 2024-11-01 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형 |
| EP3585428A1 (en) * | 2017-02-23 | 2020-01-01 | Alpha-o Peptides AG | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
| EP3681523A4 (en) * | 2017-09-15 | 2021-12-29 | The Ohio State Innovation Foundation | Vaccines and methods of making and using vaccines for prevention of respiratory syncytial virus (rsv) infections |
| EP3773698A1 (en) * | 2018-04-03 | 2021-02-17 | Sanofi | Ferritin proteins |
| JP7657727B2 (ja) * | 2019-04-02 | 2025-04-07 | サノフイ | 抗原性多量体呼吸器合胞体ウイルスポリペプチド |
-
2020
- 2020-04-01 JP JP2021558831A patent/JP7657727B2/ja active Active
- 2020-04-01 EP EP20722065.8A patent/EP3946446A1/en active Pending
- 2020-04-01 CN CN202080039105.1A patent/CN114269373A/zh active Pending
- 2020-04-01 CN CN202210425428.5A patent/CN114957407A/zh active Pending
- 2020-04-01 WO PCT/US2020/026198 patent/WO2020205986A1/en not_active Ceased
-
2021
- 2021-09-29 US US17/489,249 patent/US12454553B2/en active Active
-
2025
- 2025-01-10 JP JP2025003856A patent/JP2025063151A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000512136A (ja) | 1996-06-05 | 2000-09-19 | バイオモレキュラー・リサーチ・インスティテュート・リミテッド | 呼吸器合胞体ウイルスのgタンパク質と構造的ホモロジーを有するウイルス性ペプチド |
| WO2019032480A1 (en) | 2017-08-07 | 2019-02-14 | Avatar Medical, Llc | PROTEINS F PRE-FUSION OF RSV STABILIZED IN TERMS OF CONFORMATION |
Non-Patent Citations (3)
| Title |
|---|
| Immunology Letters,2016年,179,pp.95-101 |
| PLoS ONE,2017年,12(4):e0175384,pp.1-19 |
| Vaccine,2010年,28, pp.6242-6246 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022525431A (ja) | 2022-05-13 |
| CN114957407A (zh) | 2022-08-30 |
| WO2020205986A1 (en) | 2020-10-08 |
| US12454553B2 (en) | 2025-10-28 |
| CN114269373A (zh) | 2022-04-01 |
| JP2025063151A (ja) | 2025-04-15 |
| US20220119457A1 (en) | 2022-04-21 |
| EP3946446A1 (en) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102964264B1 (ko) | 항원성 호흡기 세포융합 바이러스 폴리펩타이드 | |
| CA3146464C (en) | Antigen specific immunotherapy employing covid-19 fusion proteins and methods of use | |
| US11904009B2 (en) | Ferritin proteins | |
| CN112638411B (zh) | 疫苗组合物 | |
| KR102252163B1 (ko) | 인플루엔자 바이러스 백신 및 그의 용도 | |
| JP2025063151A (ja) | 抗原性多量体呼吸器合胞体ウイルスポリペプチド | |
| AU2007239354B2 (en) | N protein fusion proteins of a virus in the Paramyxoviridae-protein of interest family | |
| KR20220010478A (ko) | 기도 감염의 치료 또는 예방용 서브유닛 백신 | |
| CN105792842A (zh) | 埃巴病毒疫苗 | |
| US11806394B2 (en) | Protein-based nanoparticle vaccine for metapneumovirus | |
| KR20200113226A (ko) | 인플루엔자 바이러스 백신 및 이의 용도 | |
| US20230399364A1 (en) | Immunogenic Coronavirus Fusion Proteins and Related Methods | |
| CN113227123A (zh) | 重组呼吸道合胞病毒f蛋白以及包含该蛋白的疫苗组合物 | |
| WO2022011021A1 (en) | Use of conserved peptide epitopes from sars-cov-2 for the development of a broad covid-19 vaccine | |
| US12397050B2 (en) | Universal mammalian influenza vaccine | |
| KR102765237B1 (ko) | Rsv의 f 단백질-항체 복합체 및 이를 포함하는 조성물 | |
| JP2024502823A (ja) | 安定なコロナウィルスタンパク質およびそのワクチン組成物 | |
| KR20220062080A (ko) | 전립선암 치료를 위한 면역요법 | |
| CN118176204A (zh) | 截短的流感神经氨酸酶及其使用方法 | |
| CN117377679A (zh) | 抗病毒感染的胜肽疫苗 | |
| RU2807992C2 (ru) | Антигенные полипептиды на основе последовательности респираторно-синцитиального вируса | |
| RU2811991C2 (ru) | Субъединичная вакцина для лечения или предотвращения инфекции дыхательных путей | |
| WO2026033489A1 (en) | Chimeric fusion proteins as respiratory syncytial virus (rsv) vaccines | |
| CN117177774A (zh) | Sars-cov-2受体结合结构域与载体蛋白的共价缀合物以及包含它们的疫苗组合物 | |
| EA048316B1 (ru) | Ковалентные конъюгаты рецептор-связывающего домена sars-cov-2 и белка-носителя и содержащие их вакцинные композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230303 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230303 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240209 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240312 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240612 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20240703 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240910 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250110 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250311 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250326 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7657727 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |